Additionally, other stories have demonstrated that blocking the secretion or action of soluble S100A8/A9 complex could be a promising therapeutic solution in surviving patients, who experienced decrease amounts of S100A8/A9, in comparison to non-survivors. The blocking has the likely to forestall liver damage and bacterial dissemination during the